Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, Netherlands.
Centre for Specialized Nutrition, Danone Research, Wageningen, Netherlands.
Front Immunol. 2018 Jun 14;9:1231. doi: 10.3389/fimmu.2018.01231. eCollection 2018.
DC-SIGN is an antigen uptake receptor expressed on dendritic cells (DCs) with specificity for glycans present on a broad variety of pathogens and is capable of directing its cargo to MHC-I and MHC-II pathways for the induction of CD8 and CD4 T cell responses, respectively. Therefore, DC-SIGN is a very promising target for the delivery of antigen for anti-cancer vaccination. Although the endocytic route leading to MHC-II presentation is characterized to a large extent, the mechanisms controlling DC-SIGN targeted cross-presentation of exogenous peptides on MHC-I, are not completely resolved yet. In this paper, we used imaging flow cytometry and antigen-specific CD8 T cells to investigate the intracellular fate of DC-SIGN and its cargo in human DCs. Our data demonstrates that immature DCs and toll-like receptor 4 (TLR4) stimulated DCs had similar internalization capacity and were both able to cross-present antigen targeted DC-SIGN. Interestingly, simultaneous triggering of TLR4 and DC-SIGN on DCs resulted in the translocation of cargo to the cytosol, leading to proteasome-dependent processing and increased CD8 T cell activation. Understanding the dynamics of DC-SIGN-mediated uptake and processing is essential for the design of optimal DC-SIGN-targeting vaccination strategies aimed at enhancing CD8 T cell responses.
树突细胞(DC)特异性免疫球蛋白样凝集素 2(DC-SIGN)是一种抗原摄取受体,能够识别多种病原体表面的糖基,并将其携带的抗原分别递呈给 MHC-I 类和 MHC-II 类途径,从而诱导 CD8 和 CD4 T 细胞应答。因此,DC-SIGN 是用于癌症疫苗投递的一个很有前途的靶点。尽管靶向 MHC-II 递呈的内吞途径在很大程度上已经得到了阐明,但控制 DC-SIGN 靶向递呈外源性肽段至 MHC-I 的机制尚未完全解决。在本文中,我们使用成像流式细胞术和抗原特异性 CD8 T 细胞来研究 DC-SIGN 及其携带物在人树突状细胞内的命运。我们的数据表明,未成熟的 DC 和 TLR4 刺激的 DC 具有相似的内化能力,并且都能够交叉递呈靶向 DC-SIGN 的抗原。有趣的是,同时激活 TLR4 和 DC-SIGN 会导致货物向细胞质易位,从而引发蛋白酶体依赖性加工,并增强 CD8 T 细胞的激活。了解 DC-SIGN 介导的摄取和加工的动力学对于设计旨在增强 CD8 T 细胞应答的最佳 DC-SIGN 靶向疫苗策略至关重要。